Drug Insight: histone deacetylase inhibitors—development of the new targeted anticancer agent suberoylanilide hydroxamic acid
Year: 2005
Type: review
DOI: 10.1038/ncponc0106
Authors: William Kevin Kelly, Paul A Marks
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2052453190
